APA (7th ed.) Citation

Florit, A., de Koster, E. J., Sassano, S., Alic, L., Pisano, G., van Velden, F. H. P., . . . Collarino, A. (2025). Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies. European Journal of Nuclear Medicine and Molecular Imaging, 1-15. https://doi.org/10.1007/s00259-025-07277-0

Chicago Style (17th ed.) Citation

Florit, Anita, et al. "Head-to-head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiopharmaceuticals and [18F]FDG in Gynaecological Malignancies." European Journal of Nuclear Medicine and Molecular Imaging 2025: 1-15. https://doi.org/10.1007/s00259-025-07277-0.

MLA (9th ed.) Citation

Florit, Anita, et al. "Head-to-head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiopharmaceuticals and [18F]FDG in Gynaecological Malignancies." European Journal of Nuclear Medicine and Molecular Imaging, 2025, pp. 1-15, https://doi.org/10.1007/s00259-025-07277-0.